Patents by Inventor Gordon Jay Dow

Gordon Jay Dow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Suspension containing micronized benzoyl peroxide
    Patent number: 9744150
    Abstract: Powder containing benzoyl peroxide is readily wetted by contacting the powder with a liquid containing water and one or more water-soluble organic solvents in a concentration sufficient to reduce the surface tension of the liquid to 64 dynes/cm or less. The benzoyl peroxide can then be subjected to a micronization treatment to obtain a suspension containing micronized benzoyl peroxide.
    Type: Grant
    Filed: October 15, 2010
    Date of Patent: August 29, 2017
    Assignee: Dow Pharmaceutical Sciences Inc.
    Inventor: Gordon Jay Dow
  • METHOD FOR OBTAINING A STABLE DISPERSION OF BENZOYL PEROXIDE
    Publication number: 20120115801
    Abstract: Powder containing benzoyl peroxide is readily wetted by contacting the powder with a liquid containing one or more of a polyol, a polyol, ether, and a low-carbon organic alcohol.
    Type: Application
    Filed: January 18, 2012
    Publication date: May 10, 2012
    Applicant: Dow Pharmaceutical Sciences, Inc.
    Inventor: Gordon Jay Dow
  • Azithromycin for treatment of skin disorders
    Patent number: 8143227
    Abstract: Azithromycin has increased efficacy in treating acne and other skin conditions when administered systemically at low doses, below those previously known to produce a clinical antibiotic effect.
    Type: Grant
    Filed: September 4, 2008
    Date of Patent: March 27, 2012
    Assignee: Dow Pharmaceutical Sciences, Inc.
    Inventors: Gordon Jay Dow, Bhaskar Chaudhuri, David Wade Osborne, Barry Calvarese
  • Method for wetting a powder containing benzoyl peroxide
    Publication number: 20110092562
    Abstract: Powder containing benzoyl peroxide is readily wetted by contacting the powder with a liquid containing water and one or more water-soluble organic solvents in a concentration sufficient to reduce the surface tension of the liquid to 64 dynes/cm or less.
    Type: Application
    Filed: October 15, 2010
    Publication date: April 21, 2011
    Inventor: Gordon Jay Dow
  • Azithromycin for the treatment of nodular acne
    Publication number: 20100216732
    Abstract: Azithromycin, administered systemically, is an effective treatment for nodules associated with acne vulgaris.
    Type: Application
    Filed: April 23, 2010
    Publication date: August 26, 2010
    Inventors: David Wade Osborne, Gordon Jay Dow, Bhaskar Chaudhuri, Barry Calvarese
  • Azithromycin for the treatment of nodular acne
    Patent number: 7704959
    Abstract: Azithromycin, administered systemically, is an effective treatment for nodules associated with acne vulgaris.
    Type: Grant
    Filed: December 6, 2006
    Date of Patent: April 27, 2010
    Assignee: Dow Pharmaceutical Sciences
    Inventors: David Wade Osborne, Gordon Jay Dow, Bhaskar Chaudhuri, Barry Calvarese
  • Method for obtaining a stable dispersion of benzoyl peroxide
    Publication number: 20100099733
    Abstract: Powder containing benzoyl peroxide is readily wetted by contacting the powder with a liquid containing one or more of a polyol, a polyol ether, and a low-carbon organic alcohol.
    Type: Application
    Filed: October 20, 2009
    Publication date: April 22, 2010
    Inventor: Gordon Jay Dow
  • Azithromycin for treatment of skin disorders
    Publication number: 20090062221
    Abstract: Azithromycin has increased efficacy in treating acne and other skin conditions when administered systemically at low doses, below those previously known to produce a clinical antibiotic effect.
    Type: Application
    Filed: September 4, 2008
    Publication date: March 5, 2009
    Inventors: Gordon Jay Dow, Bhaskar Chaudhuri, David Wade Osborne, Barry Calvarese
  • Azithromycin for the treatment of nodular acne
    Publication number: 20080081790
    Abstract: Azithromycin, administered systemically, is an effective treatment for nodules associated with acne vulgaris.
    Type: Application
    Filed: December 6, 2006
    Publication date: April 3, 2008
    Inventors: David Wade Osborne, Gordon Jay Dow, Bhaskar Chaudhuri, Barry Calvarese
  • "Methods and compositions for decreasing the frequency of HIV, herpesvirus and sexually transmitted bacterial infections"
    Patent number: 6165493
    Abstract: A method for decreasing the frequency of transmission of human immunodeficiency virus or herpesviruses or for preventing the transmission of or treating a sexually transmitted bacterial infection by administering to a human an anti-human immunodeficiency virus amount or an anti-herpesvirus amount or an anti-bacterial amount of cellulose acetate phthalate (CAP) or hydroxypropyl methylcellulose phthalate (HPMCP), such as in micronized form, or a combination thereof, either alone or in combination with a pharmaceutically acceptable carrier or diluent. The CAP and/or HPMCP may be employed as a suspension of micronized particles and may further contain a water miscible, non-solvent for CAP or HPMCP, such as glycerol.
    Type: Grant
    Filed: October 20, 1998
    Date of Patent: December 26, 2000
    Assignee: New York Blood Center, Inc.
    Inventors: Alexander Robert Neurath, Shibo Jiang, Asim Kumar Debnath, Nathan Strick, Gordon Jay Dow
  • Method for decreasing the frequency of transmission of viral infections using cellulose acetate phthalate or hydroxypropyl methylcellulose phthalate excipients
    Patent number: 5985313
    Abstract: A method for decreasing the frequency of transmission of human immunodeficiency virus or herpesviruses by administering to a human an anti-human immunodeficiency virus amount or an anti-herpesvirus amount of cellulose acetate phthalate (CAP) or hydroxypropyl methylcellulose phthalate (HPMCP), such as in micronized form, or a combination thereof, either alone or in combination with a pharmaceutically acceptable carrier or diluent. The CAP and/or HPMCP may be employed as a suspension of micronized particles and may further contain a water miscible, non-solvent for CAP or HPMCP, such as glycerol.
    Type: Grant
    Filed: July 8, 1998
    Date of Patent: November 16, 1999
    Assignee: New York Blood Center, Inc.
    Inventors: Alexander Robert Neurath, Asim Kumar Debnath, Shibo Jiang, Nathan Strick, Gordon Jay Dow